Sökning: L773:1758 2946
> (2020-2023) >
Using informative f...
Using informative features in machine learning based method for COVID-19 drug repurposing
-
- Aghdam, Rosa (författare)
- Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran.
-
- Habibi, Mahnaz (författare)
- Islamic Azad Univ, Dept Math, Qazvin Branch, Qazvin, Iran.
-
- Taheri, Golnaz (författare)
- KTH,Beräkningsvetenskap och beräkningsteknik (CST),Science for Life Laboratory, SciLifeLab
-
Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran Islamic Azad Univ, Dept Math, Qazvin Branch, Qazvin, Iran. (creator_code:org_t)
- 2021-09-20
- 2021
- Engelska.
-
Ingår i: Journal of Cheminformatics. - : Springer Nature. - 1758-2946. ; 13:1
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://jcheminf.bio...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Coronavirus disease 2019 (COVID-19) is caused by a novel virus named Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This virus induced a large number of deaths and millions of confirmed cases worldwide, creating a serious danger to public health. However, there are no specific therapies or drugs available for COVID-19 treatment. While new drug discovery is a long process, repurposing available drugs for COVID-19 can help recognize treatments with known clinical profiles. Computational drug repurposing methods can reduce the cost, time, and risk of drug toxicity. In this work, we build a graph as a COVID-19 related biological network. This network is related to virus targets or their associated biological processes. We select essential proteins in the constructed biological network that lead to a major disruption in the network. Our method from these essential proteins chooses 93 proteins related to COVID-19 pathology. Then, we propose multiple informative features based on drug-target and protein-protein interaction information. Through these informative features, we find five appropriate clusters of drugs that contain some candidates as potential COVID-19 treatments. To evaluate our results, we provide statistical and clinical evidence for our candidate drugs. From our proposed candidate drugs, 80% of them were studied in other studies and clinical trials.
Nyckelord
- Coronavirus disease 2019
- SARS-CoV-2
- Protein-protein interaction
- Clustering method
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas